Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational Results available

Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

ClinicalTrials.gov ID: NCT02693171

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02693171. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 4:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Post-Marketing Study to Further Assess the Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study was to assess the incidence of human anti-chimeric antibody (HACA) in high-risk neuroblastoma patients treated with Unituxin combination therapy.

Study identification

NCT ID
NCT02693171
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
United Therapeutics
Industry
Enrollment
13 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Year to 18 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2016 (Actual)
Primary completion
Dec 19, 2016 (Actual)
Completion
Dec 19, 2016 (Actual)
Last update posted
Aug 5, 2019

2016

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
University Of Alabama At Birmingham Birmingham Alabama 35233 —
Arkansas Children's Hospital Little Rock Arkansas 72202 —
Children's Hospital Los Angeles Los Angeles California 90027 —
Children's Hospital of Orange County Orange California 92868 —
Rady Children's Hospital- San Diego San Diego California 92123 —
University of Chicago Chicago Illinois 60637 —
Dana Farber Cancer Institute Boston Massachusetts 02215 —
University of Michigan - C S Mott Children's Hospital Ann Arbor Michigan 48109 —
Children's Hospitals and Clinics of Minnesota - Minneapolis Minneapolis Minnesota 55404 —
Children's Mercy Hospital Kansas City Missouri 64108 —
Columbia University Medical Center New York New York 10032 —
Carolinas Medical Center / Levine Children's Hospital Charlotte North Carolina 28203 —
Duke University Medical Center Durham North Carolina 27710 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Penn State Hershey Children's Hospital Hershey Pennsylvania 17033 —
Vanderbilt-Ingram Cancer Center Nashville Tennessee 37232 —
Cook Children's Health Care System Fort Worth Texas 76104 —
Seattle Children's Hospital Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02693171, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2019 · Synced Nov 15, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.